Welcome to our dedicated page for VSee Health news (Ticker: VSEE), a resource for investors and traders seeking the latest updates and insights on VSee Health stock.
VSee Health, Inc. (NASDAQ: VSEE) is a telehealth technology and services company whose news flow centers on AI-powered virtual care, digital health infrastructure, and capital markets developments. As a health information services provider, VSee regularly issues updates on its telehealth platform, AI initiatives, hospital partnerships, and regulatory milestones, giving investors and healthcare stakeholders insight into how the business is evolving.
Company press releases highlight product and solution launches, such as the AI-enhanced Rural Health Transformation Solution designed for rural hospitals, and initiatives that apply VSee’s configurable digital health infrastructure to specialty access, clinical workflows, and financial performance. News items also cover collaborations with health systems on tele-urgent care, teleradiology, telenursing, and high-acuity virtual care programs, as well as international projects in regions like Southeast Asia where VSee’s platform supports maternal health, primary care, and tuberculosis screening efforts.
VSEE news frequently addresses AI and security credentials, including references to FedRAMP High Authority to Operate from the U.S. Department of Health and Human Services and FedRAMP Moderate authorization related to federal telehealth deployments. These updates help readers understand how VSee positions its telehealth and AI infrastructure for hospital systems, health networks, employers, and government partners.
In addition, VSee’s news feed includes financial and corporate disclosures that complement its SEC filings, such as announcements of private placements, equity line arrangements, convertible notes, and Nasdaq listing compliance updates. Readers following VSEE news can track how the company’s technology initiatives, service contracts, and financing activities intersect, and can return to this page to review new releases as they are published.
VSEE Health (Nasdaq:VSEE) reported Q3 2025 total revenues of $3.98M, a 19% YoY increase, and YTD revenues of $10.69M, up 60% YoY. Gross margin remained ~52%. Telehealth fees rose 196% YoY to $1.44M and patient fees increased 42% to $0.88M. Cash used in operations improved to $1.52M for nine months (46% better YoY) while cash on hand was $472,759. Company cited full activation of a $10M+ teleradiology deal (100,000+ reads) and achieving FedRAMP High status. Balance sheet shows total assets of $18.71M and total current liabilities of $23.42M, with an accumulated deficit of $74.57M.
VSee Health (Nasdaq:VSEE) announced FedRAMP Moderate authorization and integration of ICU robotic assistance to enable remote clinician monitoring and intervention in intensive care units. The company reported a 150% year-over-year increase in enterprise deployments and cited recent contract wins, including an agreement to expand public mental health services in a large U.S. county. VSee highlighted platform features like omni-channel visits and EHR integrations and said pipeline partnerships could add millions in recurring revenue by Q2 2026. The release cites a U.S. telehealth market projection of $52.76 billion in 2025 with a 23.84% CAGR through 2034.
VSee Health (NASDAQ:VSEE) met with Philippine Tuberculosis Society and former vice president Leni Robredo (mayor of Naga City) on November 6, 2025 to explore digital health collaborations in Naga City focused on maternal health, primary care and TB testing.
Discussion highlighted Naga City gaps such as a 44% prenatal check-up rate versus the Department of Health target of 99%, use of mobile healthcare caravans, and PhilHealth's YAKAP subsidy of ₱1,700 (USD 29) per qualified patient for full primary care delivery. The release cites Southeast Asia digital health market size estimates of USD 17B (2024) growing to USD 38.8B by 2033, and the Philippines reaching USD 1B by 2027.
VSee noted ongoing Philippines projects (Project MAMA maternal health, TB screenings with Remedi and iOne Resource) as context for potential expansion and partnership-building in the region.
VSee Health (NASDAQ:VSEE) executed a three-year platform services agreement to provide virtual urgent care and virtual behavioral health across a health system operating more than 100 hospitals, outpatient centers, and affiliated sites. The contract is volume-based and invoice-only with no upper limit on reimbursable services, linking revenue directly to utilization. Services commence January 1, 2026. The unnamed partner is the region's sole Level 1 Trauma Center and an academic health system with longstanding medical school affiliation and multiple national rankings, which VSee characterizes as a national blueprint for replication to other top-tier academic and safety-net systems.
VSee Health (Nasdaq:VSEE) reports rapid teleradiology expansion after a FedRAMP High approval on October 28, 2025. The company says it completed 100,000+ radiology reads in six months across 18 of 35 hospitals, with full rollout to the remaining sites by December 31.
Reported operational and financial highlights include a Q2 revenue jump of 98% YoY to $3.4M with 47% margins, a disclosed $10M+ Level 1 hospital contract, a stated 285% stock surge since the FedRAMP milestone, and claimed access to a $455B federal telehealth opportunity through 2030.
VSee (Nasdaq:VSEE) announced it received an Authority to Operate (ATO) at the FedRAMP High level from the U.S. Department of Health and Human Services on October 28, 2025. The authorization permits other federal agencies to use VSee where FedRAMP High is required.
The platform is positioned for secure telehealth with enterprise encryption, HIPAA compliance, HIE interoperability, hybrid workflows, and rapid multi-site activation. In July, VSee rapidly deployed a secure telemedicine bridge for HHS ASPR to keep the only hospital on St. Croix operational after a cyberattack, clearing over 250 backlogged radiology studies within days. VSee is also advancing AIMEE, a rural hospital transformation initiative.
VSee Health (NASDAQ:VSEE) announced record-setting revenue growth and the elimination of over $5 million in legacy SPAC debt on October 23, 2025. The company said this debt removal strengthens its balance sheet, bolsters creditor confidence, and helps ensure compliance with NASDAQ listing requirements. Management framed the move as positioning VSee Health for sustained long-term growth and noted shareholder support as a key factor in the milestone.
VSee Health (Nasdaq:VSEE) announced a multi-year teleradiology contract executed May 7, 2025, with service delivery beginning June 15, 2025, for a premier Level 1 hospital system.
The deal is projected to generate approximately $10 million in gross revenue over the next two years, with provisions for an additional $5M+ in potential revenue, and is described as set to double annual recurring revenue. Revenue recognition has begun and will appear in the company's upcoming Q3 10-Q. The release lists a quoted share price of $0.479 and market cap of $8,123,227.67 as of October 20, 2025.
VSee Health (Nasdaq:VSEE) reported Second Quarter 2025 results for the three months ended June 30, 2025, with revenue of $3.4 million, up 98% year-over-year and a rise in gross profit margin from 45% to 47%. The company reported improved operating cash use in the first six months of 2025 at $765,094 versus $2,594,214 a year earlier. Cash flow from financing for H1 2025 was $746,040 compared with $3,597,841 in H1 2024, and investing cash use was minimal at $15,466.
The company attributes strong revenue growth to the acquisition and integration of iDoc Telehealth, expanded customer relationships, and new services that improved margins, while noting integration challenges remain.
VSee Health (NASDAQ:VSEE) has received approval from Nasdaq to maintain its listing status, subject to specific conditions. The company must file its delayed Q1 and Q2 2025 quarterly reports by October 15, 2025, and demonstrate compliance with Nasdaq's Equity Rule by December 1, 2025.
The company is actively working with its auditors to complete and submit the required financial reports within the extension period granted by the Nasdaq Hearings Panel. Additionally, VSee Health has confirmed its commitment to addressing and meeting the net equity requirements within the specified timeframe.
FAQ
What is the current stock price of VSee Health (VSEE)?
What is the market cap of VSee Health (VSEE)?
